Team

SKCP Announces Appointments Of Aaron Davenport and Jim Marden As Managing Directors

 NEW YORK, July 21, 2010 – SK Capital Partners, a transformational private equity firm, today announced that it has expanded its investment team with the additions of Aaron Davenport and Jim Marden as Managing Directors.  Both Mr. Davenport and Mr. Marden previously led the healthcare investing effort at Arsenal Capital Partners, where they worked closely with Barry Siadat and Jack Norris, two Managing Directors at SK Capital.

Chem M&A activity

 

InterviewChem M&A activity to fall significantly in 2009 - banker

13 August 2009 20:24  [Source: ICIS news]

Ascend Emerges

New owners of former Solutia nylon business draw on deep experience

SK Capital Partners Completes Acquisition of Solutia Inc.’s Integrated Nylon Business

NEW YORK, June 1, 2009 – SK Capital Partners, a transformational private investment firm, today announced that it has completed its previously announced acquisition of Solutia Inc.’s (NYSE: SOA) integrated nylon business, a leading supplier and manufacturer of nylon chemicals, plastics and fibers. The company had approximately $1.8 billion in revenues in 2008.

SK Capital Partners Adds Jack Norris as Managing Director

SK Capital Partners, a transformational private investment firm, today announced that it has further strengthened its investment team with the appointment of Jack Norris as a Managing Director.

Chemical & Engineering News - C&EN Talks With Barry Siadat

“Our investment strategy is to invest in businesses that we understand.”

Green Chemistry Comes naturally to Vertellus

Global trends of increased focus on healthy living and wellness, improving diets, population growth and the need for environmentally compatible products continue to shape the role of the specialty chemicals industry. Timothy Zappala, President and CEO of Vertellus Specialties and Barry Siadat, Managing Director of Arsenal Capital Partners discuss how Vertellus Specialties, Inc. is capitalizing on these life science trends.

Taking aim at the specialty chemical industry

PRIVATE-EQUITY firm Arsenal Capital Partners is taking aim at the specialty chemical industry, snapping up companies with high potential and refocusing efforts on marketing and innovation. The firm could eventually combine a number of its acquisitions into a company to take public.

Structure Breed Success

Over the next three years, AlliedSignal Inc. plans to grow revenues 8% a year through internal growth-not including the potential acquisition ofAMPInc.,the $5.75 billion industry-leading connector manufacturer. Most of that growth will come from new product development, boosting revenues to $18.5billion by the year 2000. Based on the company's performance since Lawrence A. Bossidy became CEO in 1991,the lofty goals seem well within range.